Vaccines,
Journal Year:
2022,
Volume and Issue:
10(8), P. 1181 - 1181
Published: July 26, 2022
Coronavirus
disease
2019
(COVID-19)
vaccines
effectively
protect
against
severe
and
death.
However,
the
impact
of
vaccine
used,
viral
variants,
host
factors
on
severity
remain
poorly
understood.
This
work
aimed
to
compare
COVID-19
clinical
presentations
outcomes
in
vaccinated
unvaccinated
patients
Mexico
City.
From
March
September
2021,
clinical,
demographic
characteristics,
variants
were
obtained
from
1014
individuals
with
a
documented
SARS-CoV-2
infection.
We
compared
unvaccinated,
partially
vaccinated,
fully
patients,
stratifying
by
age
groups.
also
fitted
multivariate
statistical
models
evaluate
vaccination
status,
lineages,
types,
parameters.
Most
hospitalized
unvaccinated.
In
over
61
years
old,
mortality
was
significantly
higher
individuals.
aged
31
60
years,
more
likely
be
outpatients
(46%)
than
(6.1%).
found
immune
above
old
risk
factors,
while
full
most
protective
factor
in-hospital
study
suggests
that
is
essential
reduce
comorbid
population
such
as
Mexico.
The Brazilian Journal of Infectious Diseases,
Journal Year:
2022,
Volume and Issue:
26(5), P. 102677 - 102677
Published: Aug. 8, 2022
Despite
vaccine
development
and
vaccination
programs
underway
around
the
globe,
coronavirus
disease
2019
(COVID-19)
pandemic
has
not
been
controlled
as
SARS-CoV-2
virus
is
evolving
new
variants
are
emerging.
This
study
was
conducted
to
sequence
molecularly
characterize
representing
samples
from
early
fourth
wave
in
Iraq.
Here,
we
have
performed
next-generation
sequencing
of
whole-genome
two
country's
beginning
wave.
The
were
sequenced
using
Illumina
Miseq
system,
reference
sequences
retrieved
GISAID
database.
Phylogenetic
analysis
through
Mega
software.
provides
an
initial
molecular
characterization
first
Omicron
variant
cases
recorded
country.
Our
revealed
many
mutations
on
spike
glycoprotein,
especially
receptor
binding
domain,
with
potential
impact
immune
escape
infectivity.
findings
suggest
considering
highly
mutated
immunogenic
epitope
a
for
developing
combating
ongoing
pandemic.
Viruses,
Journal Year:
2022,
Volume and Issue:
14(8), P. 1820 - 1820
Published: Aug. 19, 2022
Viruses
can
evolve
to
respond
immune
pressures
conferred
by
specific
antibodies
generated
after
vaccination
and/or
infection.
In
this
study,
an
in
vitro
system
was
developed
investigate
the
impact
of
serum-neutralising
upon
evolution
a
foot-and-mouth
disease
virus
(FMDV)
isolate.
The
presence
sub-neutralising
dilutions
antisera
delayed
onset
virus-induced
cytopathic
effect
(CPE)
up
44
h
compared
untreated
control
cultures.
Continued
passage
with
these
sera
resulted
decrease
time
complete
CPE,
suggesting
that
FMDV
cultures
adapted
escape
pressure.
These
phenotypic
changes
were
associated
three
separate
consensus-level
non-synonymous
mutations
accrued
viral
RNA-encoding
amino
acids
at
positions
VP266,
VP280
and
VP1155,
corresponding
known
epitope
sites.
High-throughput
sequencing
also
identified
further
nucleotide
substitutions
within
regions
encoding
leader
(Lpro),
VP4,
VP2
VP3
proteins.
While
association
later
adaptation
pressure
must
be
verified,
results
highlight
multiple
routes
which
populations
neutralising
support
application
simple
approach
assess
humoral
on
potentially
other
viruses.
Frontiers in Genetics,
Journal Year:
2022,
Volume and Issue:
13
Published: Sept. 26, 2022
Immunocompromised
patients
can
experience
prolonged
SARS-CoV-2
infections
in
the
setting
of
a
lack
protectivity
immunity
despite
vaccination.
As
circulating
strains
become
more
heterogeneous,
concomitant
infection
with
multiple
variants
has
an
increasing
concern.
patient
populations
represent
potential
reservoirs
for
emergence
novel
through
mutagenic
change
or
coinfection
followed
by
recombinatory
events.
Identification
coinfections
is
challenging
using
traditional
next
generation
sequencing
pipelines;
however,
targeted
genotyping
approaches
facilitate
detection.
Here
we
describe
five
COVID-19
cases
caused
different
(Delta/Omicron
BA.1
and
Omicron
BA.1/BA.2)
as
identified
multiplex
fragment
analysis.
Diagnostics,
Journal Year:
2023,
Volume and Issue:
13(5), P. 897 - 897
Published: Feb. 27, 2023
Antibodies
against
the
SARS-CoV-2
nucleocapsid
protein
are
produced
by
immune
system
in
response
to
infection,
but
most
available
vaccines
developed
fight
pandemic
spread
target
spike
protein.
The
aim
of
this
study
was
improve
detection
antibodies
providing
a
simple
and
robust
method
applicable
large
population.
For
purpose,
we
DELFIA
immunoassay
on
dried
blood
spots
(DBSs)
converting
commercially
IVD
ELISA
assay.
A
total
forty-seven
paired
plasma
were
collected
from
vaccinated
and/or
previously
SARS-CoV-2-infected
subjects.
DBS-DELFIA
resulted
wider
dynamic
range
higher
sensitivity
for
detecting
nucleocapsid.
Moreover,
showed
good
intra-assay
coefficient
variability
14.6%.
Finally,
strong
correlation
found
between
detected
immunoassays
(r
=
0.9).
Therefore,
association
sampling
with
technology
may
provide
an
easier,
minimally
invasive,
accurate
measurement
In
conclusion,
these
results
justify
further
research
develop
certified
assay
useful
diagnostics
as
well
serosurveillance
studies.
Vaccines,
Journal Year:
2022,
Volume and Issue:
10(8), P. 1181 - 1181
Published: July 26, 2022
Coronavirus
disease
2019
(COVID-19)
vaccines
effectively
protect
against
severe
and
death.
However,
the
impact
of
vaccine
used,
viral
variants,
host
factors
on
severity
remain
poorly
understood.
This
work
aimed
to
compare
COVID-19
clinical
presentations
outcomes
in
vaccinated
unvaccinated
patients
Mexico
City.
From
March
September
2021,
clinical,
demographic
characteristics,
variants
were
obtained
from
1014
individuals
with
a
documented
SARS-CoV-2
infection.
We
compared
unvaccinated,
partially
vaccinated,
fully
patients,
stratifying
by
age
groups.
also
fitted
multivariate
statistical
models
evaluate
vaccination
status,
lineages,
types,
parameters.
Most
hospitalized
unvaccinated.
In
over
61
years
old,
mortality
was
significantly
higher
individuals.
aged
31
60
years,
more
likely
be
outpatients
(46%)
than
(6.1%).
found
immune
above
old
risk
factors,
while
full
most
protective
factor
in-hospital
study
suggests
that
is
essential
reduce
comorbid
population
such
as
Mexico.